当前位置:首页 - 行情中心 - 泰格医药(300347) - 财务分析

泰格医药

(300347)

  

流通市值:277.95亿  总市值:422.68亿
流通股本:5.66亿   总股本:8.61亿

泰格医药(300347)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润3.30亿元,每股收益0.06元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益2456492.02万元,未分配利润936903.80万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产2880048.48万元,负债423556.46万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入1,801,473,935.036,832,800,615.355,025,868,260.753,250,444,279.63
营业总成本1,644,573,250.456,312,645,254.484,559,527,495.22,942,263,124.15
其他经营收益
营业利润405,838,528.231,009,419,9691,229,009,491.51444,257,860.73
利润总额405,944,308.451,003,215,119.991,222,780,755.26442,689,335.48
净利润330,083,645.62805,056,174.521,091,681,166.46362,828,303.84
每股收益
其他综合收益-87,366,018.26-53,653,137.059,646,423.7948,983,183.82
综合收益总额242,717,627.36751,403,037.471,101,327,590.25411,811,487.66
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计6,629,249,323.656,177,196,741.896,350,600,808.176,206,460,726.46
非流动资产:
非流动资产合计22,171,235,477.1522,181,598,416.2822,433,650,978.7222,298,197,031.75
资产总计28,800,484,800.828,358,795,158.1728,784,251,786.8928,504,657,758.21
流动负债:
流动负债合计2,879,679,287.512,835,474,052.172,937,853,013.043,395,689,292.77
非流动负债:
非流动负债合计1,355,885,340.221,266,895,915.051,138,805,470.531,145,266,109.01
负债合计4,235,564,627.734,102,369,967.224,076,658,483.574,540,955,401.78
所有者权益(或股东权益):
归属于母公司股东权益合计20,916,402,606.4520,959,506,514.7721,176,338,660.520,524,441,879.17
股东权益合计24,564,920,173.0724,256,425,190.9524,707,593,303.3223,963,702,356.43
负债和股东权益合计28,800,484,800.828,358,795,158.1728,784,251,786.8928,504,657,758.21
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计2,090,446,149.887,371,765,963.045,414,289,272.773,422,805,826.47
经营活动现金流出小计1,772,742,373.526,253,681,192.54,674,731,643.23,014,186,818.53
经营活动产生的现金流量净额317,703,776.361,118,084,770.54739,557,629.57408,619,007.94
投资活动产生的现金流量:
投资活动现金流入小计472,514,032.772,903,502,466.771,962,639,120.811,058,992,171.79
投资活动现金流出小计418,277,776.932,411,945,914.541,468,932,322.791,013,102,115.39
投资活动产生的现金流量净额54,236,255.84491,556,552.23493,706,798.0245,890,056.4
筹资活动产生的现金流量:
筹资活动现金流入小计348,864,549.161,422,094,305.841,268,284,871.591,102,396,907.23
筹资活动现金流出小计341,289,381.073,348,779,515.362,953,073,235.541,929,347,228.17
筹资活动产生的现金流量净额7,575,168.09-1,926,685,209.52-1,684,788,363.95-826,950,320.94
汇率变动对现金及现金等价物的影响-14,454,893.77-8,841,588.412,935,487.0814,360,075.82
现金及现金等价物净增加额365,060,306.52-325,885,475.16-448,588,449.28-358,081,180.78
期末现金及现金等价物余额2,087,668,684.21,722,608,377.681,599,905,403.561,690,412,672.06
补充资料:
现金及现金等价物的净增加额--325,885,475.16--358,081,180.78
最新报告期:2026-04-21
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
浙商证券郭双喜1.241.461.882026-04-21
中信证券陈竹,王凯旋1.301.662.102026-04-21
西部证券李梦园1.371.642.162026-04-14
中泰证券崔少煜,祝嘉琦1.281.652.182026-04-13
国泰海通周航,余文心,张子彤1.461.842.082026-04-12
TOP↑